Eupraxia Pharmaceuticals

EPRXNasdaq Canada Health Care Pharmaceuticals and Biotechnology

Market cap

$436.631 M

$6.63 -2.00%

Close of 6 Nov 2026

As of 6 Nov 2026, Eupraxia Pharmaceuticals (EPRX) has a market capitalization of $436.6M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$0.00

#3616 by revenue

Earnings

-$38.6M

Loss-making

Shares outstanding

51,939,206

Latest filing cover page

P/E ratio

—

Cap ÷ net income

What if Eupraxia Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$428,437.52

Per share 64,670× higher

Bitcoin $1.53T

$23,182.01

Per share 3,499× higher

Apple $5.02T

$76,104.37

Per share 11,487× higher

Or at a round number

$1.00B $2.00B $5.00B $10.0B

Where these numbers come from

Share counts and financials for Eupraxia Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.